A detailed history of Avidity Partners Management LP transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 1,373,000 shares of IDYA stock, worth $35.2 Million. This represents 2.67% of its overall portfolio holdings.

Number of Shares
1,373,000
Previous 1,117,000 22.92%
Holding current value
$35.2 Million
Previous $39.2 Million 10.91%
% of portfolio
2.67%
Previous 1.93%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.37 - $43.05 $7.77 Million - $11 Million
256,000 Added 22.92%
1,373,000 $43.5 Million
Q2 2024

Aug 14, 2024

BUY
$34.37 - $43.46 $10.9 Million - $13.8 Million
317,300 Added 39.68%
1,117,000 $39.2 Million
Q1 2024

May 15, 2024

SELL
$34.2 - $47.13 $24.6 Million - $33.9 Million
-720,300 Reduced 47.39%
799,700 $35.1 Million
Q4 2023

Feb 14, 2024

SELL
$24.59 - $35.83 $15.4 Million - $22.4 Million
-624,971 Reduced 29.14%
1,520,000 $54.1 Million
Q3 2023

Nov 14, 2023

SELL
$21.07 - $29.77 $17.7 Million - $25 Million
-840,729 Reduced 28.16%
2,144,971 $57.9 Million
Q2 2023

Aug 14, 2023

SELL
$13.33 - $25.53 $9.17 Million - $17.6 Million
-687,700 Reduced 18.72%
2,985,700 $70.2 Million
Q1 2023

May 15, 2023

SELL
$13.49 - $18.72 $2.04 Million - $2.83 Million
-151,400 Reduced 3.96%
3,673,400 $50.4 Million
Q4 2022

Feb 14, 2023

BUY
$14.47 - $18.17 $1.58 Million - $1.99 Million
109,400 Added 2.94%
3,824,800 $69.5 Million
Q3 2022

Nov 14, 2022

BUY
$9.24 - $15.79 $6.86 Million - $11.7 Million
742,453 Added 24.97%
3,715,400 $55.4 Million
Q2 2022

Aug 15, 2022

BUY
$8.28 - $13.88 $2.34 Million - $3.93 Million
282,947 Added 10.52%
2,972,947 $41 Million
Q1 2022

May 16, 2022

BUY
$11.18 - $24.02 $1.53 Million - $3.29 Million
137,000 Added 5.37%
2,690,000 $30.1 Million
Q4 2021

Feb 14, 2022

BUY
$20.95 - $26.88 $2.43 Million - $3.12 Million
116,000 Added 4.76%
2,553,000 $60.4 Million
Q3 2021

Nov 15, 2021

BUY
$17.26 - $27.08 $6.33 Million - $9.94 Million
367,000 Added 17.73%
2,437,000 $62.1 Million
Q2 2021

Aug 16, 2021

BUY
$17.76 - $24.83 $10.6 Million - $14.8 Million
598,000 Added 40.63%
2,070,000 $43.4 Million
Q1 2021

May 17, 2021

BUY
$13.48 - $23.77 $19.8 Million - $35 Million
1,472,000 New
1,472,000 $34.6 Million
Q4 2020

Feb 16, 2021

SELL
$12.17 - $17.52 $12.8 Million - $18.4 Million
-1,050,800 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$11.22 - $14.46 $3.14 Million - $4.05 Million
-280,300 Reduced 21.06%
1,050,800 $13.2 Million
Q2 2020

Aug 14, 2020

BUY
$3.59 - $18.57 $4.78 Million - $24.7 Million
1,331,100 New
1,331,100 $18.9 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.23B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.